Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

por Bredewold, Obbo W., Chan, Joe, Svensson, My, Bruchfeld, Annette, de Fijter, Johan W., Furuland, Hans, Grinyo, Josep M., Hartmann, Anders, Holdaas, Hallvard, Hellberg, Olof, Jardine, Alan, Mjörnstedt, Lars, Skov, Karin, Smerud, Knut T., Soveri, Inga, Sørensen, Søren S., Zonneveld, Anton-Jan van, Fellström, Bengt
Publicado 2022